PofoliaShared via Pofolia

Pain Practice· 2018Q1

Spinal Cord Stimulation: Clinical Efficacy and Potential Mechanisms

Andrei D. Sdrulla, Yun Guan, Srinivasa N. Raja

Short summary

Spinal cord stimulation (SCS) effectively treats chronic neuropathic pain, offering a safer alternative to opioids, with randomized trials showing benefits for conditions like failed back surgery syndrome.

AI-generated from the title and abstract; the full text is not read.

Key points

  • SCS is a safe and effective treatment for chronic neuropathic pain, including failed back surgery syndrome.
  • It offers an alternative to pain medications like opioids.
  • Conventional SCS is believed to work via dorsal column Aβ fiber activation and gate control theory.
  • Novel waveforms (high-frequency, burst) show potential clinical superiority but require mechanistic clarification.

AI-generated from the title and abstract; the full text is not read.

Abstract

Spinal cord stimulation (SCS) is a minimally invasive therapy used for the treatment of chronic neuropathic pain. SCS is a safe and effective alternative to medications such as opioids, and multiple randomized controlled studies have demonstrated efficacy for difficult-to-treat neuropathic conditions such as failed back surgery syndrome. Conventional SCS is believed mediate pain relief via activation of dorsal column Aβ fibers, resulting in variable effects on sensory and pain thresholds, and measurable alterations in higher order cortical processing. Although potentiation of inhibition, as suggested by Wall and Melzack's gate control theory, continues to be the leading explanatory model, other segmental and supraspinal mechanisms have been described. Novel, non-standard, stimulation waveforms such as high-frequency and burst have been shown in some studies to be clinically superior to conventional SCS, however their mechanisms of action remain to be determined. Additional studies are needed, both mechanistic and clinical, to better understand optimal stimulation strategies for different neuropathic conditions, improve patient selection and optimize efficacy.

The authors' abstract, as published at the source. Pain Practice, 2018 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Anesthesiology and Pain Medicine

Anesthesiology and Pain MedicineMedicine